Molecular cytogenetic test for specific chromosome regions in suspected myeloid conditions.
Fluorescence in-situ hybridisation (FISH) is a targeted molecular cytogenetic technique used for the investigation of precise chromosome regions, particularly relevant when a specific condition is suspected. The technique binds a colour labelled DNA probe to a specific region on the patient chromosomes. As this is a targeted test it is important when requesting a FISH test to indicate the clinical condition that is being tested for.
A broad range of FISH is available for the detection of non-random rearrangements, deletions and chromosome aneuploidy that are associated with a haematological malignancy. FISH is a targeted investigation and has the benefit of screening large numbers of cells to detect clonal abnormalities.
Targeted FISH in Haematology - Myeloid
For diagnosis, classification, and prognosis in haem-oncology
See list of individual targets above
FISH
2 – 14 days
73314 – Criteria applies
Contact 1800 822 999 for pricing details if not eligible for Medicare rebate.
Standard pathology request form.
Bone marrow Aspirate
Lithium heparin tube
Doctor Collect. No additional sample required. Test is performed with Chromosome analysis.